Curaleaf Holdings (CURLF) Other Non Operating Income (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Other Non Operating Income of -$4.1 million for Q1 2026, down 235.43% year-on-year from $3.0 million in Q1 2025, and down 234.8% on a QoQ basis from $3.0 million in Q4 2025.
Curaleaf Holdings (CURLF) Other Non Operating Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Other Non Operating Income for 8 consecutive years, with -$4.1 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non Operating Income fell 235.43% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 106.97% YoY) and the FY2025 annual result came in at $5.6 million, down 65.08% from the prior year.
- Other Non Operating Income declined to -$4.1 million in Q1 2026 per CURLF's latest filing, from $3.0 million in the prior quarter.
- Over the last five years, Other Non Operating Income for CURLF reached as high as $18.5 million in Q2 2022 and fell as low as -$4.1 million in Q1 2026.
- A 5-year average of $2.4 million and a median of $1.8 million in 2025 frame the typical range for Other Non Operating Income.
- The largest YoY upside for Other Non Operating Income was 402.11% in 2024 against a maximum downside of 383.16% in 2024.
- Year by year, Other Non Operating Income stood at $2.7 million in 2022, then plunged by 245.47% to -$3.9 million in 2023, then soared by 402.11% to $11.7 million in 2024, then tumbled by 74.29% to $3.0 million in 2025, then sank by 234.8% to -$4.1 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$4.1 million, $3.0 million, and -$2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.07 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 11.73 Mn |
| Sep 30, 2024 | 4.73 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -3.88 Mn |
| Sep 30, 2023 | -2.80 Mn |
| Jun 30, 2023 | 7.36 Mn |
| Mar 31, 2023 | -487,000.00 |
| Dec 31, 2022 | 2.67 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 18.46 Mn |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | -22.31 Mn |
| Sep 30, 2021 | -13.90 Mn |
| Jun 30, 2021 | 18.37 Mn |